VECTORIE

Vector-borne Risks for Europe: Risk assessment and control of West Nile and Chikungunya virus (VECTORIE)

 Coordinatore ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM 

 Organization address address: 's Gravendijkwal 230
city: ROTTERDAM
postcode: 3015CE

contact info
Titolo: Mr.
Nome: Wim
Cognome: Leep
Email: send email
Telefono: +31 10 704 34 51
Fax: +31 10 704 47 60

 Nazionalità Coordinatore Netherlands [NL]
 Sito del progetto http://vectorie.eu/
 Totale costo 3˙791˙100 €
 EC contributo 2˙784˙402 €
 Programma FP7-HEALTH
Specific Programme "Cooperation": Health
 Code Call FP7-HEALTH-2010-single-stage
 Funding Scheme CP-FP
 Anno di inizio 2010
 Periodo (anno-mese-giorno) 2010-11-01   -   2014-01-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM

 Organization address address: 's Gravendijkwal 230
city: ROTTERDAM
postcode: 3015CE

contact info
Titolo: Mr.
Nome: Wim
Cognome: Leep
Email: send email
Telefono: +31 10 704 34 51
Fax: +31 10 704 47 60

NL (ROTTERDAM) coordinator 691˙400.00
2    WAGENINGEN UNIVERSITY

 Organization address address: DROEVENDAALSESTEEG 4
city: WAGENINGEN
postcode: 6708 PB

contact info
Titolo: Mr.
Nome: Rudie
Cognome: Jullens
Email: send email
Telefono: +31 317 485829
Fax: +31 317 483457

NL (WAGENINGEN) participant 562˙180.00
3    LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN

 Organization address address: GESCHWISTER SCHOLL PLATZ 1
city: MUENCHEN
postcode: 80539

contact info
Titolo: Prof.
Nome: Gerd
Cognome: Sutter
Email: send email
Telefono: +49 89 2180 2610
Fax: +49 89 2180 99 2610

DE (MUENCHEN) participant 459˙900.00
4    UNIVERSITE D'AIX MARSEILLE

 Organization address address: Boulevard Charles Livon 58
city: Marseille
postcode: 13284

contact info
Titolo: Ms.
Nome: Céline
Cognome: Damon
Email: send email
Telefono: +33 4 91 31 97 97
Fax: +33 6 98 87 72 76

FR (Marseille) participant 304˙500.00
5    LATVIJAS BIOMEDICINAS PETIJUMU UN STUDIJU CENTRS

 Organization address address: RATSUPITES IELA 1
city: RIGA
postcode: 1067

contact info
Nome: Lilita
Cognome: Kundzina
Email: send email
Telefono: +371 67808204
Fax: +371 67442407

LV (RIGA) participant 242˙844.75
6    INSTITUT PASTEUR

 Organization address address: RUE DU DOCTEUR ROUX 25-28
city: PARIS CEDEX 15
postcode: 75724

contact info
Titolo: Dr.
Nome: Nadia
Cognome: Khelef
Email: send email
Telefono: +33 1 40 61 33 78
Fax: +33 1 40 61 39 40

FR (PARIS CEDEX 15) participant 192˙022.00
7    CYTOS BIOTECHLOLOGY AG

 Organization address address: "Waggistrasse, 25"
city: ZURICH-SCHLIEREN
postcode: 8952

contact info
Titolo: Mr.
Nome: Jakob
Cognome: Schlapbach
Email: send email
Telefono: +41 44 733 4747
Fax: +41 44 733 4740

CH (ZURICH-SCHLIEREN) participant 168˙155.25
8    SZENT ISTVAN UNIVERSITY

 Organization address address: Pater Karoly utca 1
city: GODOLLO
postcode: 2100

contact info
Titolo: Mr.
Nome: Imre
Cognome: Tatár
Email: send email
Telefono: +36 28 522 000
Fax: +36 28 522 008

HU (GODOLLO) participant 163˙400.00
9    UNIVERSITE DE LA MEDITERRANEE D'AIX-MARSEILLE II

 Organization address address: Boulevard Charles Livon, Jardin du Pharo 58
city: MARSEILLE
postcode: 13284

contact info
Titolo: Ms.
Nome: Céline
Cognome: Damon
Email: send email
Telefono: +33 4 91 31 97 97
Fax: +33 6 98 87 72 76

FR (MARSEILLE) participant 0.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

vectorie    candidates    wnv    spread    diseases    vector    strategies    risk    vaccine    neuroinvasive    borne    chikv    infections    caused    disease    virus    monitor   

 Obiettivo del progetto (Objective)

'VECTORIE provides for a multidisciplinary approach combining the expertise of (basic) virology, entomology and advanced vaccinology to monitor the spread of and diagnose, prevent and treat infections caused by West Nile virus (WNV) and Chikungunya virus (CHIKV). VECTORIE therefore addresses Europe’s need to prepare for these vector-borne diseases along three strands:

Vector biology: WNV and CHIKV are emerging mosquito-borne viral diseases. Generating novel knowledge on avian and mammalian host susceptibility and vector competence of the two main vectors of WNV and CHIKV, will lead to important insights necessary for determining the type of surveillance system appropriate for European countries to detect and predict emerging WNV and/or CHIKV outbreaks.

Virulence & pathogenesis: VECTORIE addresses the need for understanding how CHIKV and the four WNV lineages circulating in Europe differ in their capacity to cause neuroinvasive disease. These studies will improve Europe’s ability to monitor the spread of these infections and will lead to diagnostic and prognostic tools as well as novel intervention strategies.

Vaccination strategies: The severity of WNV and CHIKV neuroinvasive disease, the long term sequelae reported from infected individuals and the negative impact of these infections on the blood transfusion system collectively justify the development of safe and effective vaccines against these infections. VECTORIE brings together a platform of technologies using either virus-like particles or Modified vaccinia Ankara vaccine candidates, for the development of novel mono- and bivalent vaccine candidates against WNV and CHIKV.

VECTORIE’s integrated approach will largely contribute to adequate risk assessment and risk mitigation of the emerging health threat caused by WNV and CHIKV infections in Europe.'

Altri progetti dello stesso programma (FP7-HEALTH)

MICROENVIMET (2008)

Understanding and fighting metastasis by modulating the tumour microenvironment through interference with the protease network

Read More  

AAVEYE (2008)

GENE THERAPY FOR INHERITED SEVERE PHOTORECEPTOR DISEASES

Read More  

IACT (2013)

Immunostimulatory Agonist antibodies for Cancer Therapy

Read More